デフォルト表紙
市場調査レポート
商品コード
1140002

デルモコスメティック市場:製品別、治療法別、流通チャネル別、エンドユーザー別:世界の機会分析および産業予測、2021-2030年

Dermocosmetics Market By Product, By Treatment, By Distribution Channel, By End-user : Global Opportunity Analysis and Industry Forecast, 2021-2030

出版日: | 発行: Allied Market Research | ページ情報: 英文 310 Pages | 納期: 2~3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
デルモコスメティック市場:製品別、治療法別、流通チャネル別、エンドユーザー別:世界の機会分析および産業予測、2021-2030年
出版日: 2022年07月01日
発行: Allied Market Research
ページ情報: 英文 310 Pages
納期: 2~3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

デルモコスメティックの世界市場は、2021年の511億米ドルから2022年から2030年にかけてCAGR11.1%で成長し、2030年には1,304億6,060万米ドルを獲得すると想定されています。

化粧品と皮膚科学は、2つの医療の流れが一緒になってダーモコスメティクスを形成しています。皮膚や髪に塗布し、乾燥肌、脂性肌、ニキビ、吹き出物、シミ、跡などの肌トラブルに対応する化粧品はすべてデルモコスメティックと呼ばれます。スキンケアにおける化粧品の必要性は、その効果に関する意識の高まりによるところが大きく、業界の技術的進歩は、今後数年間でダーマコスメティックスの需要に大きな影響を与えると予想されます。

消費者は、外見が自分の個性を引き立てるため、外見に対する自意識が強くなっています。加齢、しわ、にきび、小じわなどの影響を軽減するために、さまざまなデルモコスメティックを使用して肌を保護し、美白することにお金をかけることを好むようになってきているのです。さらに、eコマースサイトでの買い物の動向は、顧客の多忙なライフスタイルやオンラインチャネルでの最も便利な購入方法の採用により、予測期間を通じてスキンケア用デルモコスメティック市場の業績にとって不可欠であると予測されます。化粧品には、肌にさまざまな悪影響を及ぼす可能性のある化学物質が含まれています。化粧品メーカー各社は、天然成分を使用した新製品や魅力的なパッケージの導入など、最先端の技術で化粧品アイテムの売上を伸ばしています。予測では、これらの要因が市場の収益成長を加速させると予想されます。

COVID-19の大流行により、大半の産業が閉鎖されました。輸出入の中断、サプライチェーンの問題、いくつかの製造施設の閉鎖により、新製品の製造が遅れることになりました。パンデミックの期間中、健康的なスキンケアを維持するためにデルモコスメティックが有効であったため、デルモコスメティックの需要が少し増加しました。いくつかの国では封鎖されたため、人々は治療の予約を続けることができませんでした。その結果、彼らは自宅でダーマコスメを使ったスキンケアを続けられるようになったのです。

また、各国政府の規制やガイドラインにより、ダーモトロジストがオンラインで診察を行うようになりました。しかし、パンデミックの期間中は、高い製品コストと消費者の嗜好の変化が市場の成長を制限しました。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 市場の概要

  • 市場の定義と範囲
  • 主な調査結果
    • 主な投資ポケット
  • ポーターのファイブフォース分析
  • 主要企業のポジショニング
  • 市場力学
    • 促進要因
    • 抑制要因
    • 機会
  • COVID-19 影響分析
  • バリューチェーン分析
  • 市場シェア分析
  • 規制ガイドライン
  • 主要規制の分析
  • 特許情勢

第4章 デルモコスメティック市場:製品別

  • 概要
    • 市場規模・予測
  • スキンケア
    • 主な市場動向、成長要因、機会
    • 市場規模・予測:地域別
    • 市場分析:国別
  • ヘアケア
    • 主な市場動向、成長要因、機会
    • 市場規模・予測:地域別
    • 市場分析:国別

第5章 デルモコスメティック市場:治療法別

  • 概要
    • 市場規模・予測
  • 皮膚
    • 主な市場動向、成長要因、機会
    • 市場規模・予測:地域別
    • 市場分析:国別
  • 毛髪
    • 主な市場動向、成長要因、機会
    • 市場規模・予測:地域別
    • 市場分析:国別

第6章 デルモコスメティック市場:流通チャネル別

  • 概要
    • 市場規模・予測
  • 薬局・小売店
    • 主な市場動向、成長要因、機会
    • 市場規模・予測:地域別
    • 市場分析:国別
  • オンライン
    • 主な市場動向、成長要因、機会
    • 市場規模・予測:地域別
    • 市場分析:国別

第7章 デルモコスメティック市場:エンドユーザー別

  • 概要
    • 市場規模・予測
  • クリニック、メディカル・スパ、サロン
    • 主な市場動向、成長要因、機会
    • 市場規模・予測:地域別
    • 市場分析:国別
  • 病院
    • 主要な市場動向、成長要因、機会
    • 市場規模・予測:地域別
    • 市場分析:国別
  • アットホーム
    • 主な市場動向、成長要因、機会
    • 市場規模・予測:地域別
    • 市場分析:国別

第8章 デルモコスメティック市場:地域別

  • 概要
    • 市場規模・予測
  • 北米
    • 主要動向と機会
    • 北米市場規模・予測:製品別
    • 北米市場規模・予測:治療法別
    • 北米市場規模・予測:流通チャネル別
    • 北米市場規模・予測:エンドユーザー別
    • 北米市場規模・予測:国別
      • 米国
      • カナダ
      • メキシコ
  • 欧州
    • 主な動向と機会
    • 欧州の市場規模・予測:製品別
    • 欧州市場規模・予測:治療法別
    • 欧州市場規模・予測:流通チャネル別
    • 欧州市場規模・予測:エンドユーザー別
    • 欧州市場規模・予測:国別
      • ドイツ
      • フランス
      • イタリア
      • スペイン
      • 英国
      • その他欧州
  • アジア太平洋地域
    • 主な動向と機会
    • アジア太平洋地域の市場規模・予測:製品別
    • アジア太平洋地域の市場規模・予測:治療法別
    • アジア太平洋地域の市場規模・予測:流通チャネル別
    • アジア太平洋地域の市場規模・予測:エンドユーザー別
    • アジア太平洋地域の市場規模・予測:国別
      • 中国
      • 日本
      • インド
      • 韓国
      • オーストラリア
      • その他アジア太平洋地域
  • LAMEA
    • 主な動向と機会
    • LAMEAの市場規模・予測:製品別
    • LAMEAの市場規模・予測:治療法別
    • LAMEAの市場規模・予測:流通チャネル別
    • LAMEAの市場規模・予測:エンドユーザー別
    • LAMEA市場の市場規模・予測:国別
      • ブラジル
      • サウジアラビア
      • アラブ首長国連邦
      • 南アフリカ共和国
      • その他ラテンアメリカ地域

第9章 企業情勢

  • イントロダクション
  • 主要成功戦略
  • 主要10社の製品マッピング
  • 競合ダッシュボード
  • 競合のヒートマップ
  • 主な発展

第10章 企業プロファイル

  • johnson & johnson, inc.
  • Bausch Health Companies Inc.
  • galderma
  • Procter & Gamble
  • Allergan plc
  • L'Oreal S.A
  • beiersdorf
  • Kanebo Cosmetics Inc.
  • Estee Lauder Companies Inc.
  • Shiseido Company
図表

LIST OF TABLES

  • TABLE 1. GLOBAL DERMOCOSMETICS MARKET, BY PRODUCT, 2021-2030 ($MILLION)
  • TABLE 2. DERMOCOSMETICS MARKET SIZE, FOR SKIN CARE, BY REGION, 2021-2030 ($MILLION)
  • TABLE 3. DERMOCOSMETICS MARKET FOR SKIN CARE BY COUNTRY, 2021-2030 ($MILLION)
  • TABLE 4. DERMOCOSMETICS MARKET SIZE, FOR HAIR CARE, BY REGION, 2021-2030 ($MILLION)
  • TABLE 5. DERMOCOSMETICS MARKET FOR HAIR CARE BY COUNTRY, 2021-2030 ($MILLION)
  • TABLE 6. GLOBAL DERMOCOSMETICS MARKET, BY TREATMENT, 2021-2030 ($MILLION)
  • TABLE 7. DERMOCOSMETICS MARKET SIZE, FOR SKIN, BY REGION, 2021-2030 ($MILLION)
  • TABLE 8. DERMOCOSMETICS MARKET FOR SKIN BY COUNTRY, 2021-2030 ($MILLION)
  • TABLE 9. DERMOCOSMETICS MARKET SIZE, FOR HAIR, BY REGION, 2021-2030 ($MILLION)
  • TABLE 10. DERMOCOSMETICS MARKET FOR HAIR BY COUNTRY, 2021-2030 ($MILLION)
  • TABLE 11. GLOBAL DERMOCOSMETICS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 ($MILLION)
  • TABLE 12. DERMOCOSMETICS MARKET SIZE, FOR PHARMACY AND RETAIL STORES, BY REGION, 2021-2030 ($MILLION)
  • TABLE 13. DERMOCOSMETICS MARKET FOR PHARMACY AND RETAIL STORES BY COUNTRY, 2021-2030 ($MILLION)
  • TABLE 14. DERMOCOSMETICS MARKET SIZE, FOR ONLINE, BY REGION, 2021-2030 ($MILLION)
  • TABLE 15. DERMOCOSMETICS MARKET FOR ONLINE BY COUNTRY, 2021-2030 ($MILLION)
  • TABLE 16. GLOBAL DERMOCOSMETICS MARKET, BY END-USER, 2021-2030 ($MILLION)
  • TABLE 17. DERMOCOSMETICS MARKET SIZE, FOR CLINICS, MEDICAL SPAS, AND SALONS, BY REGION, 2021-2030 ($MILLION)
  • TABLE 18. DERMOCOSMETICS MARKET FOR CLINICS, MEDICAL SPAS, AND SALONS BY COUNTRY, 2021-2030 ($MILLION)
  • TABLE 19. DERMOCOSMETICS MARKET SIZE, FOR HOSPITALS, BY REGION, 2021-2030 ($MILLION)
  • TABLE 20. DERMOCOSMETICS MARKET FOR HOSPITALS BY COUNTRY, 2021-2030 ($MILLION)
  • TABLE 21. DERMOCOSMETICS MARKET SIZE, FOR AT-HOME, BY REGION, 2021-2030 ($MILLION)
  • TABLE 22. DERMOCOSMETICS MARKET FOR AT-HOME BY COUNTRY, 2021-2030 ($MILLION)
  • TABLE 23. DERMOCOSMETICS MARKET, BY REGION, 2021-2030 ($MILLION)
  • TABLE 24. NORTH AMERICA DERMOCOSMETICS MARKET, BY PRODUCT, 2021-2030 ($MILLION)
  • TABLE 25. NORTH AMERICA DERMOCOSMETICS MARKET, BY TREATMENT, 2021-2030 ($MILLION)
  • TABLE 26. NORTH AMERICA DERMOCOSMETICS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 ($MILLION)
  • TABLE 27. NORTH AMERICA DERMOCOSMETICS MARKET, BY END-USER, 2021-2030 ($MILLION)
  • TABLE 28. NORTH AMERICA DERMOCOSMETICS MARKET, BY COUNTRY, 2021-2030 ($MILLION)
  • TABLE 29. U.S. DERMOCOSMETICS MARKET, BY PRODUCT, 2021-2030 ($MILLION)
  • TABLE 30. U.S. DERMOCOSMETICS MARKET, BY TREATMENT, 2021-2030 ($MILLION)
  • TABLE 31. U.S. DERMOCOSMETICS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 ($MILLION)
  • TABLE 32. U.S. DERMOCOSMETICS MARKET, BY END-USER, 2021-2030 ($MILLION)
  • TABLE 33. CANADA DERMOCOSMETICS MARKET, BY PRODUCT, 2021-2030 ($MILLION)
  • TABLE 34. CANADA DERMOCOSMETICS MARKET, BY TREATMENT, 2021-2030 ($MILLION)
  • TABLE 35. CANADA DERMOCOSMETICS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 ($MILLION)
  • TABLE 36. CANADA DERMOCOSMETICS MARKET, BY END-USER, 2021-2030 ($MILLION)
  • TABLE 37. MEXICO DERMOCOSMETICS MARKET, BY PRODUCT, 2021-2030 ($MILLION)
  • TABLE 38. MEXICO DERMOCOSMETICS MARKET, BY TREATMENT, 2021-2030 ($MILLION)
  • TABLE 39. MEXICO DERMOCOSMETICS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 ($MILLION)
  • TABLE 40. MEXICO DERMOCOSMETICS MARKET, BY END-USER, 2021-2030 ($MILLION)
  • TABLE 41. EUROPE DERMOCOSMETICS MARKET, BY PRODUCT, 2021-2030 ($MILLION)
  • TABLE 42. EUROPE DERMOCOSMETICS MARKET, BY TREATMENT, 2021-2030 ($MILLION)
  • TABLE 43. EUROPE DERMOCOSMETICS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 ($MILLION)
  • TABLE 44. EUROPE DERMOCOSMETICS MARKET, BY END-USER, 2021-2030 ($MILLION)
  • TABLE 45. EUROPE DERMOCOSMETICS MARKET, BY COUNTRY, 2021-2030 ($MILLION)
  • TABLE 46. GERMANY DERMOCOSMETICS MARKET, BY PRODUCT, 2021-2030 ($MILLION)
  • TABLE 47. GERMANY DERMOCOSMETICS MARKET, BY TREATMENT, 2021-2030 ($MILLION)
  • TABLE 48. GERMANY DERMOCOSMETICS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 ($MILLION)
  • TABLE 49. GERMANY DERMOCOSMETICS MARKET, BY END-USER, 2021-2030 ($MILLION)
  • TABLE 50. FRANCE DERMOCOSMETICS MARKET, BY PRODUCT, 2021-2030 ($MILLION)
  • TABLE 51. FRANCE DERMOCOSMETICS MARKET, BY TREATMENT, 2021-2030 ($MILLION)
  • TABLE 52. FRANCE DERMOCOSMETICS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 ($MILLION)
  • TABLE 53. FRANCE DERMOCOSMETICS MARKET, BY END-USER, 2021-2030 ($MILLION)
  • TABLE 54. ITALY DERMOCOSMETICS MARKET, BY PRODUCT, 2021-2030 ($MILLION)
  • TABLE 55. ITALY DERMOCOSMETICS MARKET, BY TREATMENT, 2021-2030 ($MILLION)
  • TABLE 56. ITALY DERMOCOSMETICS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 ($MILLION)
  • TABLE 57. ITALY DERMOCOSMETICS MARKET, BY END-USER, 2021-2030 ($MILLION)
  • TABLE 58. SPAIN DERMOCOSMETICS MARKET, BY PRODUCT, 2021-2030 ($MILLION)
  • TABLE 59. SPAIN DERMOCOSMETICS MARKET, BY TREATMENT, 2021-2030 ($MILLION)
  • TABLE 60. SPAIN DERMOCOSMETICS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 ($MILLION)
  • TABLE 61. SPAIN DERMOCOSMETICS MARKET, BY END-USER, 2021-2030 ($MILLION)
  • TABLE 62. UNITED KINGDOM DERMOCOSMETICS MARKET, BY PRODUCT, 2021-2030 ($MILLION)
  • TABLE 63. UNITED KINGDOM DERMOCOSMETICS MARKET, BY TREATMENT, 2021-2030 ($MILLION)
  • TABLE 64. UNITED KINGDOM DERMOCOSMETICS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 ($MILLION)
  • TABLE 65. UNITED KINGDOM DERMOCOSMETICS MARKET, BY END-USER, 2021-2030 ($MILLION)
  • TABLE 66. REST OF EUROPE DERMOCOSMETICS MARKET, BY PRODUCT, 2021-2030 ($MILLION)
  • TABLE 67. REST OF EUROPE DERMOCOSMETICS MARKET, BY TREATMENT, 2021-2030 ($MILLION)
  • TABLE 68. REST OF EUROPE DERMOCOSMETICS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 ($MILLION)
  • TABLE 69. REST OF EUROPE DERMOCOSMETICS MARKET, BY END-USER, 2021-2030 ($MILLION)
  • TABLE 70. ASIA-PACIFIC DERMOCOSMETICS MARKET, BY PRODUCT, 2021-2030 ($MILLION)
  • TABLE 71. ASIA-PACIFIC DERMOCOSMETICS MARKET, BY TREATMENT, 2021-2030 ($MILLION)
  • TABLE 72. ASIA-PACIFIC DERMOCOSMETICS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 ($MILLION)
  • TABLE 73. ASIA-PACIFIC DERMOCOSMETICS MARKET, BY END-USER, 2021-2030 ($MILLION)
  • TABLE 74. ASIA-PACIFIC DERMOCOSMETICS MARKET, BY COUNTRY, 2021-2030 ($MILLION)
  • TABLE 75. CHINA DERMOCOSMETICS MARKET, BY PRODUCT, 2021-2030 ($MILLION)
  • TABLE 76. CHINA DERMOCOSMETICS MARKET, BY TREATMENT, 2021-2030 ($MILLION)
  • TABLE 77. CHINA DERMOCOSMETICS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 ($MILLION)
  • TABLE 78. CHINA DERMOCOSMETICS MARKET, BY END-USER, 2021-2030 ($MILLION)
  • TABLE 79. JAPAN DERMOCOSMETICS MARKET, BY PRODUCT, 2021-2030 ($MILLION)
  • TABLE 80. JAPAN DERMOCOSMETICS MARKET, BY TREATMENT, 2021-2030 ($MILLION)
  • TABLE 81. JAPAN DERMOCOSMETICS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 ($MILLION)
  • TABLE 82. JAPAN DERMOCOSMETICS MARKET, BY END-USER, 2021-2030 ($MILLION)
  • TABLE 83. INDIA DERMOCOSMETICS MARKET, BY PRODUCT, 2021-2030 ($MILLION)
  • TABLE 84. INDIA DERMOCOSMETICS MARKET, BY TREATMENT, 2021-2030 ($MILLION)
  • TABLE 85. INDIA DERMOCOSMETICS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 ($MILLION)
  • TABLE 86. INDIA DERMOCOSMETICS MARKET, BY END-USER, 2021-2030 ($MILLION)
  • TABLE 87. SOUTH KOREA DERMOCOSMETICS MARKET, BY PRODUCT, 2021-2030 ($MILLION)
  • TABLE 88. SOUTH KOREA DERMOCOSMETICS MARKET, BY TREATMENT, 2021-2030 ($MILLION)
  • TABLE 89. SOUTH KOREA DERMOCOSMETICS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 ($MILLION)
  • TABLE 90. SOUTH KOREA DERMOCOSMETICS MARKET, BY END-USER, 2021-2030 ($MILLION)
  • TABLE 91. AUSTRALIA DERMOCOSMETICS MARKET, BY PRODUCT, 2021-2030 ($MILLION)
  • TABLE 92. AUSTRALIA DERMOCOSMETICS MARKET, BY TREATMENT, 2021-2030 ($MILLION)
  • TABLE 93. AUSTRALIA DERMOCOSMETICS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 ($MILLION)
  • TABLE 94. AUSTRALIA DERMOCOSMETICS MARKET, BY END-USER, 2021-2030 ($MILLION)
  • TABLE 95. REST OF ASIA-PACIFIC DERMOCOSMETICS MARKET, BY PRODUCT, 2021-2030 ($MILLION)
  • TABLE 96. REST OF ASIA-PACIFIC DERMOCOSMETICS MARKET, BY TREATMENT, 2021-2030 ($MILLION)
  • TABLE 97. REST OF ASIA-PACIFIC DERMOCOSMETICS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 ($MILLION)
  • TABLE 98. REST OF ASIA-PACIFIC DERMOCOSMETICS MARKET, BY END-USER, 2021-2030 ($MILLION)
  • TABLE 99. LAMEA DERMOCOSMETICS MARKET, BY PRODUCT, 2021-2030 ($MILLION)
  • TABLE 100. LAMEA DERMOCOSMETICS MARKET, BY TREATMENT, 2021-2030 ($MILLION)
  • TABLE 101. LAMEA DERMOCOSMETICS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 ($MILLION)
  • TABLE 102. LAMEA DERMOCOSMETICS MARKET, BY END-USER, 2021-2030 ($MILLION)
  • TABLE 103. LAMEA DERMOCOSMETICS MARKET, BY COUNTRY, 2021-2030 ($MILLION)
  • TABLE 104. BRAZIL DERMOCOSMETICS MARKET, BY PRODUCT, 2021-2030 ($MILLION)
  • TABLE 105. BRAZIL DERMOCOSMETICS MARKET, BY TREATMENT, 2021-2030 ($MILLION)
  • TABLE 106. BRAZIL DERMOCOSMETICS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 ($MILLION)
  • TABLE 107. BRAZIL DERMOCOSMETICS MARKET, BY END-USER, 2021-2030 ($MILLION)
  • TABLE 108. SAUDI ARABIA DERMOCOSMETICS MARKET, BY PRODUCT, 2021-2030 ($MILLION)
  • TABLE 109. SAUDI ARABIA DERMOCOSMETICS MARKET, BY TREATMENT, 2021-2030 ($MILLION)
  • TABLE 110. SAUDI ARABIA DERMOCOSMETICS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 ($MILLION)
  • TABLE 111. SAUDI ARABIA DERMOCOSMETICS MARKET, BY END-USER, 2021-2030 ($MILLION)
  • TABLE 112. UNITED ARAB EMIRATES DERMOCOSMETICS MARKET, BY PRODUCT, 2021-2030 ($MILLION)
  • TABLE 113. UNITED ARAB EMIRATES DERMOCOSMETICS MARKET, BY TREATMENT, 2021-2030 ($MILLION)
  • TABLE 114. UNITED ARAB EMIRATES DERMOCOSMETICS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 ($MILLION)
  • TABLE 115. UNITED ARAB EMIRATES DERMOCOSMETICS MARKET, BY END-USER, 2021-2030 ($MILLION)
  • TABLE 116. SOUTH AFRICA DERMOCOSMETICS MARKET, BY PRODUCT, 2021-2030 ($MILLION)
  • TABLE 117. SOUTH AFRICA DERMOCOSMETICS MARKET, BY TREATMENT, 2021-2030 ($MILLION)
  • TABLE 118. SOUTH AFRICA DERMOCOSMETICS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 ($MILLION)
  • TABLE 119. SOUTH AFRICA DERMOCOSMETICS MARKET, BY END-USER, 2021-2030 ($MILLION)
  • TABLE 120. REST OF LATIN AMERICA DERMOCOSMETICS MARKET, BY PRODUCT, 2021-2030 ($MILLION)
  • TABLE 121. REST OF LATIN AMERICA DERMOCOSMETICS MARKET, BY TREATMENT, 2021-2030 ($MILLION)
  • TABLE 122. REST OF LATIN AMERICA DERMOCOSMETICS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 ($MILLION)
  • TABLE 123. REST OF LATIN AMERICA DERMOCOSMETICS MARKET, BY END-USER, 2021-2030 ($MILLION)
  • TABLE 124.JOHNSON & JOHNSON, INC.: COMPANY SNAPSHOT
  • TABLE 125.JOHNSON & JOHNSON, INC.: OPERATING SEGMENTS
  • TABLE 126.JOHNSON & JOHNSON, INC.: PRODUCT PORTFOLIO
  • TABLE 127.JOHNSON & JOHNSON, INC.: NET SALES,
  • TABLE 128.JOHNSON & JOHNSON, INC.: KEY STRATERGIES
  • TABLE 129.BAUSCH HEALTH COMPANIES INC.: COMPANY SNAPSHOT
  • TABLE 130.BAUSCH HEALTH COMPANIES INC.: OPERATING SEGMENTS
  • TABLE 131.BAUSCH HEALTH COMPANIES INC.: PRODUCT PORTFOLIO
  • TABLE 132.BAUSCH HEALTH COMPANIES INC.: NET SALES,
  • TABLE 133.BAUSCH HEALTH COMPANIES INC.: KEY STRATERGIES
  • TABLE 134.GALDERMA: COMPANY SNAPSHOT
  • TABLE 135.GALDERMA: OPERATING SEGMENTS
  • TABLE 136.GALDERMA: PRODUCT PORTFOLIO
  • TABLE 137.GALDERMA: NET SALES,
  • TABLE 138.GALDERMA: KEY STRATERGIES
  • TABLE 139.PROCTER & GAMBLE: COMPANY SNAPSHOT
  • TABLE 140.PROCTER & GAMBLE: OPERATING SEGMENTS
  • TABLE 141.PROCTER & GAMBLE: PRODUCT PORTFOLIO
  • TABLE 142.PROCTER & GAMBLE: NET SALES,
  • TABLE 143.PROCTER & GAMBLE: KEY STRATERGIES
  • TABLE 144.ALLERGAN PLC: COMPANY SNAPSHOT
  • TABLE 145.ALLERGAN PLC: OPERATING SEGMENTS
  • TABLE 146.ALLERGAN PLC: PRODUCT PORTFOLIO
  • TABLE 147.ALLERGAN PLC: NET SALES,
  • TABLE 148.ALLERGAN PLC: KEY STRATERGIES
  • TABLE 149.L'OREAL S.A: COMPANY SNAPSHOT
  • TABLE 150.L'OREAL S.A: OPERATING SEGMENTS
  • TABLE 151.L'OREAL S.A: PRODUCT PORTFOLIO
  • TABLE 152.L'OREAL S.A: NET SALES,
  • TABLE 153.L'OREAL S.A: KEY STRATERGIES
  • TABLE 154.BEIERSDORF: COMPANY SNAPSHOT
  • TABLE 155.BEIERSDORF: OPERATING SEGMENTS
  • TABLE 156.BEIERSDORF: PRODUCT PORTFOLIO
  • TABLE 157.BEIERSDORF: NET SALES,
  • TABLE 158.BEIERSDORF: KEY STRATERGIES
  • TABLE 159.KANEBO COSMETICS INC.: COMPANY SNAPSHOT
  • TABLE 160.KANEBO COSMETICS INC.: OPERATING SEGMENTS
  • TABLE 161.KANEBO COSMETICS INC.: PRODUCT PORTFOLIO
  • TABLE 162.KANEBO COSMETICS INC.: NET SALES,
  • TABLE 163.KANEBO COSMETICS INC.: KEY STRATERGIES
  • TABLE 164.ESTEE LAUDER COMPANIES INC.: COMPANY SNAPSHOT
  • TABLE 165.ESTEE LAUDER COMPANIES INC.: OPERATING SEGMENTS
  • TABLE 166.ESTEE LAUDER COMPANIES INC.: PRODUCT PORTFOLIO
  • TABLE 167.ESTEE LAUDER COMPANIES INC.: NET SALES,
  • TABLE 168.ESTEE LAUDER COMPANIES INC.: KEY STRATERGIES
  • TABLE 169.SHISEIDO COMPANY: COMPANY SNAPSHOT
  • TABLE 170.SHISEIDO COMPANY: OPERATING SEGMENTS
  • TABLE 171.SHISEIDO COMPANY: PRODUCT PORTFOLIO
  • TABLE 172.SHISEIDO COMPANY: NET SALES,
  • TABLE 173.SHISEIDO COMPANY: KEY STRATERGIES

LIST OF FIGURES

  • FIGURE 1.DERMOCOSMETICS MARKET SEGMENTATION
  • FIGURE 2.DERMOCOSMETICS MARKET,2021-2030
  • FIGURE 3.DERMOCOSMETICS MARKET,2021-2030
  • FIGURE 4. TOP INVESTMENT POCKETS, BY REGION
  • FIGURE 5.PORTER FIVE-1
  • FIGURE 6.PORTER FIVE-2
  • FIGURE 7.PORTER FIVE-3
  • FIGURE 8.PORTER FIVE-4
  • FIGURE 9.PORTER FIVE-5
  • FIGURE 10.TOP PLAYER POSITIONING
  • FIGURE 11.DERMOCOSMETICS MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
  • FIGURE 12.VALUE CHAIN ANALYSIS
  • FIGURE 13.MARKET SHARE ANALYSIS
  • FIGURE 14.REGULATORY GUIDELINES
  • FIGURE 15.KEY REGULATION ANALYSIS
  • FIGURE 16.PATENT ANALYSIS BY COMPANY
  • FIGURE 17.PATENT ANALYSIS BY COUNTRY
  • FIGURE 18.DERMOCOSMETICS MARKET,BY PRODUCT,2021(%)
  • FIGURE 19.COMPARATIVE SHARE ANALYSIS OF SKIN CARE DERMOCOSMETICS MARKET,2021-2030(%)
  • FIGURE 20.COMPARATIVE SHARE ANALYSIS OF HAIR CARE DERMOCOSMETICS MARKET,2021-2030(%)
  • FIGURE 21.DERMOCOSMETICS MARKET,BY TREATMENT,2021(%)
  • FIGURE 22.COMPARATIVE SHARE ANALYSIS OF SKIN DERMOCOSMETICS MARKET,2021-2030(%)
  • FIGURE 23.COMPARATIVE SHARE ANALYSIS OF HAIR DERMOCOSMETICS MARKET,2021-2030(%)
  • FIGURE 24.DERMOCOSMETICS MARKET,BY DISTRIBUTION CHANNEL,2021(%)
  • FIGURE 25.COMPARATIVE SHARE ANALYSIS OF PHARMACY AND RETAIL STORES DERMOCOSMETICS MARKET,2021-2030(%)
  • FIGURE 26.COMPARATIVE SHARE ANALYSIS OF ONLINE DERMOCOSMETICS MARKET,2021-2030(%)
  • FIGURE 27.DERMOCOSMETICS MARKET,BY END-USER,2021(%)
  • FIGURE 28.COMPARATIVE SHARE ANALYSIS OF CLINICS, MEDICAL SPAS, AND SALONS DERMOCOSMETICS MARKET,2021-2030(%)
  • FIGURE 29.COMPARATIVE SHARE ANALYSIS OF HOSPITALS DERMOCOSMETICS MARKET,2021-2030(%)
  • FIGURE 30.COMPARATIVE SHARE ANALYSIS OF AT-HOME DERMOCOSMETICS MARKET,2021-2030(%)
  • FIGURE 31.DERMOCOSMETICS MARKET BY REGION,2021
  • FIGURE 32.U.S. DERMOCOSMETICS MARKET,2021-2030($MILLION)
  • FIGURE 33.CANADA DERMOCOSMETICS MARKET,2021-2030($MILLION)
  • FIGURE 34.MEXICO DERMOCOSMETICS MARKET,2021-2030($MILLION)
  • FIGURE 35.GERMANY DERMOCOSMETICS MARKET,2021-2030($MILLION)
  • FIGURE 36.FRANCE DERMOCOSMETICS MARKET,2021-2030($MILLION)
  • FIGURE 37.ITALY DERMOCOSMETICS MARKET,2021-2030($MILLION)
  • FIGURE 38.SPAIN DERMOCOSMETICS MARKET,2021-2030($MILLION)
  • FIGURE 39.UNITED KINGDOM DERMOCOSMETICS MARKET,2021-2030($MILLION)
  • FIGURE 40.REST OF EUROPE DERMOCOSMETICS MARKET,2021-2030($MILLION)
  • FIGURE 41.CHINA DERMOCOSMETICS MARKET,2021-2030($MILLION)
  • FIGURE 42.JAPAN DERMOCOSMETICS MARKET,2021-2030($MILLION)
  • FIGURE 43.INDIA DERMOCOSMETICS MARKET,2021-2030($MILLION)
  • FIGURE 44.SOUTH KOREA DERMOCOSMETICS MARKET,2021-2030($MILLION)
  • FIGURE 45.AUSTRALIA DERMOCOSMETICS MARKET,2021-2030($MILLION)
  • FIGURE 46.REST OF ASIA-PACIFIC DERMOCOSMETICS MARKET,2021-2030($MILLION)
  • FIGURE 47.BRAZIL DERMOCOSMETICS MARKET,2021-2030($MILLION)
  • FIGURE 48.SAUDI ARABIA DERMOCOSMETICS MARKET,2021-2030($MILLION)
  • FIGURE 49.UNITED ARAB EMIRATES DERMOCOSMETICS MARKET,2021-2030($MILLION)
  • FIGURE 50.SOUTH AFRICA DERMOCOSMETICS MARKET,2021-2030($MILLION)
  • FIGURE 51.REST OF LATIN AMERICA DERMOCOSMETICS MARKET,2021-2030($MILLION)
  • FIGURE 52. TOP WINNING STRATEGIES, BY YEAR
  • FIGURE 53. TOP WINNING STRATEGIES, BY DEVELOPMENT
  • FIGURE 54. TOP WINNING STRATEGIES, BY COMPANY
  • FIGURE 55.PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 56.COMPETITIVE DASHBOARD
  • FIGURE 57.COMPETITIVE HEATMAP OF TOP 10 KEY PLAYERS
  • FIGURE 58.JOHNSON & JOHNSON, INC..: NET SALES ,($MILLION)
  • FIGURE 59.BAUSCH HEALTH COMPANIES INC..: NET SALES ,($MILLION)
  • FIGURE 60.GALDERMA.: NET SALES ,($MILLION)
  • FIGURE 61.PROCTER & GAMBLE.: NET SALES ,($MILLION)
  • FIGURE 62.ALLERGAN PLC.: NET SALES ,($MILLION)
  • FIGURE 63.L'OREAL S.A.: NET SALES ,($MILLION)
  • FIGURE 64.BEIERSDORF.: NET SALES ,($MILLION)
  • FIGURE 65.KANEBO COSMETICS INC..: NET SALES ,($MILLION)
  • FIGURE 66.ESTEE LAUDER COMPANIES INC..: NET SALES ,($MILLION)
  • FIGURE 67.SHISEIDO COMPANY.: NET SALES ,($MILLION)
目次
Product Code: A11130

The global dermocosmetics market is envisioned to garner $13, 0460.6 million by 2030, growing from $51,100 million in 2021 at a CAGR of 11.1% from 2022 to 2030.

Cosmetics and dermatology are two medical streams that are combined together to form dermocosmetics. All cosmetics products that may be applied to the skin or hair and that address particular skin issues such as dry skin, oily skin, skin ailments including acne, pimples, blemishes, marks, and others are referred to as dermacosmetics. Need of cosmetics in skin care is majorly due to  rising awareness regarding its effectiveness and technological advancements in the industry are expected to have a significant impact on demand for dermacosmetics in the years to come.

Consumers are becoming more self-conscious about their appearance as it enhances their personality. In order to lessen the effects of aging, wrinkles, acne, and fine lines, they are increasingly preferring to spend more money on protecting and whitening their skin by using various dermocosmetic products. Furthermore, the trend towards shopping on e-commerce websites is projected to be essential for the performance of the skincare dermacosmetics market throughout the forecast period, due to customers' busy lifestyles and adopting most convenient ways to buy through online channel. Cosmetic products contain chemical compounds which can have a variety of negative effects on skin. Manufacturing businesses have used cutting-edge techniques to boost sales of their cosmetics items, such as introduction of new products with all-natural ingredients and attractive packaging. In the forecast, these factors are projected to accelerate the market revenue growth.

The majority of industries were shut down as a result of the COVID-19 pandemic. Import and export interruption, supply chain issues, and shutting down of several manufacturing facilities resulted in delaying the manufacturing of new products. Due to dermocosmetics' effectiveness in maintaining a healthy skincare routine during the pandemic, dermocosmetics witnessed a little boost in demand. Due to the lockdown in several countries, people were unable to continue their therapy appointments. As a result, they were able to continue practicing skincare using dermacosmetics at home itself.

Additionally, dermotologists started conducting online consultations, due to the restriction and guidelines provided by various governments. However, during the pandemic, high product costs and a change in consumer tastes restricted the market growth.

The key players profiled in the dermocosmetics market report include Johnson & Johnson, Bausch Health Companies Inc., Galderma, Procter & Gamble, AbbVie, L'Oreal, Beiersdorf, Kanebo Cosmetics Inc., Estee Lauder Companies, Shiseido Company, and ZO Skin Health Inc.

Key Benefits For Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the dermocosmetics market analysis from 2021 to 2030 to identify the prevailing dermocosmetics market opportunities.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the dermocosmetics market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global dermocosmetics market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

By Product

  • Skin Care
  • Hair Care

By Treatment

  • Skin
  • Hair

By Distribution Channel

  • Pharmacy and Retail Stores
  • Online

By End-user

  • Clinics, Medical Spas, and Salons
  • Hospitals
  • At-Home

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • Italy
    • Spain
    • United Kingdom
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • United Arab Emirates
    • South Africa
    • Rest of Latin America
  • Key Market Players
    • johnson & johnson, inc.
    • Bausch Health Companies Inc.
    • galderma
    • Procter & Gamble
    • Allergan plc
    • L'Oreal S.A
    • beiersdorf
    • Kanebo Cosmetics Inc.
    • Estee Lauder Companies Inc.
    • Shiseido Company

TABLE OF CONTENTS

CHAPTER 1:INTRODUCTION

  • 1.1.Report description
  • 1.2.Key market segments
  • 1.3.Key benefits to the stakeholders
  • 1.4.Research Methodology
    • 1.4.1.Secondary research
    • 1.4.2.Primary research
    • 1.4.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

  • 2.1.Key findings of the study
  • 2.2.CXO Perspective

CHAPTER 3:MARKET OVERVIEW

  • 3.1.Market definition and scope
  • 3.2.Key findings
    • 3.2.1.Top investment pockets
  • 3.3.Porter's five forces analysis
  • 3.4.Top player positioning
  • 3.5.Market dynamics
    • 3.5.1.Drivers
    • 3.5.2.Restraints
    • 3.5.3.Opportunities
  • 3.6.COVID-19 Impact Analysis on the market
  • 3.7.Value Chain Analysis
  • 3.8.Market Share Analysis
  • 3.9.Regulatory Guidelines
  • 3.10.Key Regulation Analysis
  • 3.11.Patent Landscape

CHAPTER 4: DERMOCOSMETICS MARKET, BY PRODUCT

  • 4.1 Overview
    • 4.1.1 Market size and forecast
  • 4.2 Skin Care
    • 4.2.1 Key market trends, growth factors and opportunities
    • 4.2.2 Market size and forecast, by region
    • 4.2.3 Market analysis by country
  • 4.3 Hair Care
    • 4.3.1 Key market trends, growth factors and opportunities
    • 4.3.2 Market size and forecast, by region
    • 4.3.3 Market analysis by country

CHAPTER 5: DERMOCOSMETICS MARKET, BY TREATMENT

  • 5.1 Overview
    • 5.1.1 Market size and forecast
  • 5.2 Skin
    • 5.2.1 Key market trends, growth factors and opportunities
    • 5.2.2 Market size and forecast, by region
    • 5.2.3 Market analysis by country
  • 5.3 Hair
    • 5.3.1 Key market trends, growth factors and opportunities
    • 5.3.2 Market size and forecast, by region
    • 5.3.3 Market analysis by country

CHAPTER 6: DERMOCOSMETICS MARKET, BY DISTRIBUTION CHANNEL

  • 6.1 Overview
    • 6.1.1 Market size and forecast
  • 6.2 Pharmacy and Retail Stores
    • 6.2.1 Key market trends, growth factors and opportunities
    • 6.2.2 Market size and forecast, by region
    • 6.2.3 Market analysis by country
  • 6.3 Online
    • 6.3.1 Key market trends, growth factors and opportunities
    • 6.3.2 Market size and forecast, by region
    • 6.3.3 Market analysis by country

CHAPTER 7: DERMOCOSMETICS MARKET, BY END-USER

  • 7.1 Overview
    • 7.1.1 Market size and forecast
  • 7.2 Clinics, Medical Spas, and Salons
    • 7.2.1 Key market trends, growth factors and opportunities
    • 7.2.2 Market size and forecast, by region
    • 7.2.3 Market analysis by country
  • 7.3 Hospitals
    • 7.3.1 Key market trends, growth factors and opportunities
    • 7.3.2 Market size and forecast, by region
    • 7.3.3 Market analysis by country
  • 7.4 At-Home
    • 7.4.1 Key market trends, growth factors and opportunities
    • 7.4.2 Market size and forecast, by region
    • 7.4.3 Market analysis by country

CHAPTER 8: DERMOCOSMETICS MARKET, BY REGION

  • 8.1 Overview
    • 8.1.1 Market size and forecast
  • 8.2 North America
    • 8.2.1 Key trends and opportunities
    • 8.2.2 North America Market size and forecast, by Product
    • 8.2.3 North America Market size and forecast, by Treatment
    • 8.2.4 North America Market size and forecast, by Distribution Channel
    • 8.2.5 North America Market size and forecast, by End-user
    • 8.2.6 North America Market size and forecast, by country
      • 8.2.6.1 U.S.
      • 8.2.6.1.1 Market size and forecast, by Product
      • 8.2.6.1.2 Market size and forecast, by Treatment
      • 8.2.6.1.3 Market size and forecast, by Distribution Channel
      • 8.2.6.1.4 Market size and forecast, by End-user
      • 8.2.6.2 Canada
      • 8.2.6.2.1 Market size and forecast, by Product
      • 8.2.6.2.2 Market size and forecast, by Treatment
      • 8.2.6.2.3 Market size and forecast, by Distribution Channel
      • 8.2.6.2.4 Market size and forecast, by End-user
      • 8.2.6.3 Mexico
      • 8.2.6.3.1 Market size and forecast, by Product
      • 8.2.6.3.2 Market size and forecast, by Treatment
      • 8.2.6.3.3 Market size and forecast, by Distribution Channel
      • 8.2.6.3.4 Market size and forecast, by End-user
  • 8.3 Europe
    • 8.3.1 Key trends and opportunities
    • 8.3.2 Europe Market size and forecast, by Product
    • 8.3.3 Europe Market size and forecast, by Treatment
    • 8.3.4 Europe Market size and forecast, by Distribution Channel
    • 8.3.5 Europe Market size and forecast, by End-user
    • 8.3.6 Europe Market size and forecast, by country
      • 8.3.6.1 Germany
      • 8.3.6.1.1 Market size and forecast, by Product
      • 8.3.6.1.2 Market size and forecast, by Treatment
      • 8.3.6.1.3 Market size and forecast, by Distribution Channel
      • 8.3.6.1.4 Market size and forecast, by End-user
      • 8.3.6.2 France
      • 8.3.6.2.1 Market size and forecast, by Product
      • 8.3.6.2.2 Market size and forecast, by Treatment
      • 8.3.6.2.3 Market size and forecast, by Distribution Channel
      • 8.3.6.2.4 Market size and forecast, by End-user
      • 8.3.6.3 Italy
      • 8.3.6.3.1 Market size and forecast, by Product
      • 8.3.6.3.2 Market size and forecast, by Treatment
      • 8.3.6.3.3 Market size and forecast, by Distribution Channel
      • 8.3.6.3.4 Market size and forecast, by End-user
      • 8.3.6.4 Spain
      • 8.3.6.4.1 Market size and forecast, by Product
      • 8.3.6.4.2 Market size and forecast, by Treatment
      • 8.3.6.4.3 Market size and forecast, by Distribution Channel
      • 8.3.6.4.4 Market size and forecast, by End-user
      • 8.3.6.5 United Kingdom
      • 8.3.6.5.1 Market size and forecast, by Product
      • 8.3.6.5.2 Market size and forecast, by Treatment
      • 8.3.6.5.3 Market size and forecast, by Distribution Channel
      • 8.3.6.5.4 Market size and forecast, by End-user
      • 8.3.6.6 Rest of Europe
      • 8.3.6.6.1 Market size and forecast, by Product
      • 8.3.6.6.2 Market size and forecast, by Treatment
      • 8.3.6.6.3 Market size and forecast, by Distribution Channel
      • 8.3.6.6.4 Market size and forecast, by End-user
  • 8.4 Asia-Pacific
    • 8.4.1 Key trends and opportunities
    • 8.4.2 Asia-Pacific Market size and forecast, by Product
    • 8.4.3 Asia-Pacific Market size and forecast, by Treatment
    • 8.4.4 Asia-Pacific Market size and forecast, by Distribution Channel
    • 8.4.5 Asia-Pacific Market size and forecast, by End-user
    • 8.4.6 Asia-Pacific Market size and forecast, by country
      • 8.4.6.1 China
      • 8.4.6.1.1 Market size and forecast, by Product
      • 8.4.6.1.2 Market size and forecast, by Treatment
      • 8.4.6.1.3 Market size and forecast, by Distribution Channel
      • 8.4.6.1.4 Market size and forecast, by End-user
      • 8.4.6.2 Japan
      • 8.4.6.2.1 Market size and forecast, by Product
      • 8.4.6.2.2 Market size and forecast, by Treatment
      • 8.4.6.2.3 Market size and forecast, by Distribution Channel
      • 8.4.6.2.4 Market size and forecast, by End-user
      • 8.4.6.3 India
      • 8.4.6.3.1 Market size and forecast, by Product
      • 8.4.6.3.2 Market size and forecast, by Treatment
      • 8.4.6.3.3 Market size and forecast, by Distribution Channel
      • 8.4.6.3.4 Market size and forecast, by End-user
      • 8.4.6.4 South Korea
      • 8.4.6.4.1 Market size and forecast, by Product
      • 8.4.6.4.2 Market size and forecast, by Treatment
      • 8.4.6.4.3 Market size and forecast, by Distribution Channel
      • 8.4.6.4.4 Market size and forecast, by End-user
      • 8.4.6.5 Australia
      • 8.4.6.5.1 Market size and forecast, by Product
      • 8.4.6.5.2 Market size and forecast, by Treatment
      • 8.4.6.5.3 Market size and forecast, by Distribution Channel
      • 8.4.6.5.4 Market size and forecast, by End-user
      • 8.4.6.6 Rest of Asia-Pacific
      • 8.4.6.6.1 Market size and forecast, by Product
      • 8.4.6.6.2 Market size and forecast, by Treatment
      • 8.4.6.6.3 Market size and forecast, by Distribution Channel
      • 8.4.6.6.4 Market size and forecast, by End-user
  • 8.5 LAMEA
    • 8.5.1 Key trends and opportunities
    • 8.5.2 LAMEA Market size and forecast, by Product
    • 8.5.3 LAMEA Market size and forecast, by Treatment
    • 8.5.4 LAMEA Market size and forecast, by Distribution Channel
    • 8.5.5 LAMEA Market size and forecast, by End-user
    • 8.5.6 LAMEA Market size and forecast, by country
      • 8.5.6.1 Brazil
      • 8.5.6.1.1 Market size and forecast, by Product
      • 8.5.6.1.2 Market size and forecast, by Treatment
      • 8.5.6.1.3 Market size and forecast, by Distribution Channel
      • 8.5.6.1.4 Market size and forecast, by End-user
      • 8.5.6.2 Saudi Arabia
      • 8.5.6.2.1 Market size and forecast, by Product
      • 8.5.6.2.2 Market size and forecast, by Treatment
      • 8.5.6.2.3 Market size and forecast, by Distribution Channel
      • 8.5.6.2.4 Market size and forecast, by End-user
      • 8.5.6.3 United Arab Emirates
      • 8.5.6.3.1 Market size and forecast, by Product
      • 8.5.6.3.2 Market size and forecast, by Treatment
      • 8.5.6.3.3 Market size and forecast, by Distribution Channel
      • 8.5.6.3.4 Market size and forecast, by End-user
      • 8.5.6.4 South Africa
      • 8.5.6.4.1 Market size and forecast, by Product
      • 8.5.6.4.2 Market size and forecast, by Treatment
      • 8.5.6.4.3 Market size and forecast, by Distribution Channel
      • 8.5.6.4.4 Market size and forecast, by End-user
      • 8.5.6.5 Rest of Latin America
      • 8.5.6.5.1 Market size and forecast, by Product
      • 8.5.6.5.2 Market size and forecast, by Treatment
      • 8.5.6.5.3 Market size and forecast, by Distribution Channel
      • 8.5.6.5.4 Market size and forecast, by End-user

CHAPTER 9: COMPANY LANDSCAPE

  • 9.1. Introduction
  • 9.2. Top winning strategies
  • 9.3. Product Mapping of Top 10 Player
  • 9.4. Competitive Dashboard
  • 9.5. Competitive Heatmap
  • 9.6. Key developments

CHAPTER 10: COMPANY PROFILES

  • 10.1 johnson & johnson, inc.
    • 10.1.1 Company overview
    • 10.1.2 Company snapshot
    • 10.1.3 Operating business segments
    • 10.1.4 Product portfolio
    • 10.1.5 Business performance
    • 10.1.6 Key strategic moves and developments
  • 10.2 Bausch Health Companies Inc.
    • 10.2.1 Company overview
    • 10.2.2 Company snapshot
    • 10.2.3 Operating business segments
    • 10.2.4 Product portfolio
    • 10.2.5 Business performance
    • 10.2.6 Key strategic moves and developments
  • 10.3 galderma
    • 10.3.1 Company overview
    • 10.3.2 Company snapshot
    • 10.3.3 Operating business segments
    • 10.3.4 Product portfolio
    • 10.3.5 Business performance
    • 10.3.6 Key strategic moves and developments
  • 10.4 Procter & Gamble
    • 10.4.1 Company overview
    • 10.4.2 Company snapshot
    • 10.4.3 Operating business segments
    • 10.4.4 Product portfolio
    • 10.4.5 Business performance
    • 10.4.6 Key strategic moves and developments
  • 10.5 Allergan plc
    • 10.5.1 Company overview
    • 10.5.2 Company snapshot
    • 10.5.3 Operating business segments
    • 10.5.4 Product portfolio
    • 10.5.5 Business performance
    • 10.5.6 Key strategic moves and developments
  • 10.6 L'Oreal S.A
    • 10.6.1 Company overview
    • 10.6.2 Company snapshot
    • 10.6.3 Operating business segments
    • 10.6.4 Product portfolio
    • 10.6.5 Business performance
    • 10.6.6 Key strategic moves and developments
  • 10.7 beiersdorf
    • 10.7.1 Company overview
    • 10.7.2 Company snapshot
    • 10.7.3 Operating business segments
    • 10.7.4 Product portfolio
    • 10.7.5 Business performance
    • 10.7.6 Key strategic moves and developments
  • 10.8 Kanebo Cosmetics Inc.
    • 10.8.1 Company overview
    • 10.8.2 Company snapshot
    • 10.8.3 Operating business segments
    • 10.8.4 Product portfolio
    • 10.8.5 Business performance
    • 10.8.6 Key strategic moves and developments
  • 10.9 Estee Lauder Companies Inc.
    • 10.9.1 Company overview
    • 10.9.2 Company snapshot
    • 10.9.3 Operating business segments
    • 10.9.4 Product portfolio
    • 10.9.5 Business performance
    • 10.9.6 Key strategic moves and developments
  • 10.10 Shiseido Company
    • 10.10.1 Company overview
    • 10.10.2 Company snapshot
    • 10.10.3 Operating business segments
    • 10.10.4 Product portfolio
    • 10.10.5 Business performance
    • 10.10.6 Key strategic moves and developments